Revenue Forecast

The revenue estimate for the base year 2021 is $9,198.7 million with a CAGR of 13.2% for the study period 2021-2028.

The Impact of the Top 3 Strategic Imperatives on the Heart Valves Industry

Disruptive Technologies

• Why:
  • Technologies such as 3D printing, continuous cardiac monitoring devices, and robotics positively impact heart valve device development, efficiency, and adoption rates.
  • The development of minimally invasive procedures is increasing the adoption rate. Transcatheter valve surgeries are rapidly replacing traditional open-heart surgeries.

• Frost Perspective:

  • Rapid technological advances will enhance the durability and clinical outcomes of heart valves.
  • Advanced technologies such as 3D printing, artificial intelligence (AI), advanced imaging, and robotics will drive the heart valves industry in the next growth phase.

Competitive Intensity

• Why:
  • Frost & Sullivan's analysis shows that the heart valves industry is highly consolidated, with significant market share held by leading players such as Edwards Lifesciences, Abbott, Medtronic, Boston Scientific, and Atrium. These companies have a strong product pipeline and heavily invest in R&D to maintain competitiveness.
  • Many new companies are also entering this industry with innovative technologies.
• Frost Perspective:
  • Companies are focusing on minimally invasive and transcatheter surgeries to gain a competitive advantage and will continue to do so during the forecast period.
  • Key vendors will continue introducing innovative products, especially in the mitral and tricuspid valve repair and replacement space, with enhanced clinical outcomes in the next 3 to 5 years.

Transformative Megatrends

• Why:
  • Advancements in AI are resulting in early disease detection and enhanced therapy outcomes.
  • Rising implementations of AI-based solutions for diagnosis, treatment planning, and clinical decision support will positively impact the industry.
• Frost Perspective:
  • Companies will increasingly focus on developing AI-based solutions to increase therapy outcomes, identify post-procedure complications, and increase patient therapy engagement.
  • Such strategies will assist in overcoming underdiagnosis issues.

Scope of Analysis

• Frost & Sullivan provides a detailed overview of the heart valves industry in this analysis.

• Market sizing will cover historic and forecast data by segment and region.

• Market sizing and forecasts cover mitral, aortic, pulmonary, and tricuspid heart valves.

• Market sizing covers mechanical, transcatheter, and tissue heart valves used for heart valve replacement and repair surgeries. The analysis does not cover other devices used in heart valve repair surgeries, such as robotic devices and annuloplasty rings.

• The analysis does not cover allograft and autograft.

Segmentation

Heart Valves Industry

Mitral

• Transcatheter mitral valve repair
• Transcatheter mitral valve replacement
• Mechanical
• Biological/Tissue

Aortic

• Mechanical
• Biological/Tissue
• Transcatheter

Tricuspid

• Includes transcatheter mechanical and biological/tissue valves

Pulmonary

• Includes transcatheter mechanical and biological/tissue valves

Competitive Environment